Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Vaccine Development
100%
Streptococcus Group A
100%
Pathogenesis
100%
Group A Streptococcal Infection
25%
Rheumatic Fever
25%
Allergic Glomerulonephritis
25%
Infectious Agent
12%
Infection
12%
Mortality Rate
12%
Amoxicillin
12%
Long Term Exposure
12%
Rheumatic Heart Disease
12%
Pharyngitis
12%
Necrotizing Fasciitis
12%
Recurrent Infection
12%
Streptococcus pyogenes
12%
Streptococcus Vaccine
12%
Pyoderma
12%
Toxic Shock Syndrome
12%
Diseases
12%
Keyphrases
Vaccine Development
100%
Group A Streptococcus
100%
Rheumatic Fever
22%
Poststreptococcal Acute Glomerulonephritis (PSAGN)
22%
Adhesion
11%
Life-limiting Conditions
11%
Developed Countries
11%
Gram-positive
11%
Excess Mortality
11%
Human Body
11%
Host Immune Response
11%
Age of Infection
11%
High-income Countries
11%
Prolonged Exposure
11%
Fever
11%
Rheumatic Heart Disease
11%
Pharyngitis
11%
Necrotizing Fasciitis
11%
Streptococcus Pyogenes (S. pyogenes)
11%
Global Epidemic
11%
Infection Exposure
11%
Immune-mediated Diseases
11%
Pyoderma
11%
Streptococcal Toxic Shock Syndrome
11%
Universal Groups
11%
Potential Vaccine Candidate
11%
Recurrent Infections
11%
Mild Symptoms
11%
Group A Streptococcal Infection
11%
Immunology and Microbiology
Streptococcus Group A
100%
Infectious Disease
40%
Infection
40%
Allergic Glomerulonephritis
20%
Rheumatic Fever
20%
Infectious Agent
10%
Mortality Rate
10%
Necrotizing Fasciitis
10%
Streptococcus pyogenes
10%
Rheumatic Heart Disease
10%
Streptococcus Vaccine
10%
Pharyngitis
10%
Immune System
10%